Abstract
The combined implementation of quality by design principles and green analytical chemistry leads to development of green micellar HPLC method for analysis of atorvastatin calcium and amlodipine besylate in binary mixtures and in their tablet dosage forms within 8 min. A two-level fractional factorial design was implemented for screening of different method parameters affecting chromatographic responses. Box–Behnken design was then used to study and optimize the most critical parameters. The optimum chromatographic conditions obtained from Box–Behnken design involved the use of a mixture of 0.17 M sodium dodecyl sulfate solution adjusted to pH 2.9 and 10%v/v n-butanol as mobile phase at a flow rate of 1.5 mL min−1 and column temperature kept at 45 ºC. The stationary phase was X-Bridge™ (150 mm × 4.6 mm, 5 μm) column. The fluorescence detection was programmed at 276/378 nm (excitation/ emission) for the first 5 mins for atorvastatin then switched to 366/442 nm (excitation/emission) for amlodipine. A linear response was obtained over the ranges of 0.2–25 μg mL−1 for both drugs. The proposed method was validated and successfully implemented for the simultaneous determination of cited drugs in their different tablet dosage forms. The method was additionally applied to content uniformity testing according to the official guidelines. The application of quality by design principles and green analytical chemistry results in development of robust green method with less trial and error experiments.
Similar content being viewed by others
References
Namieśnik J (2000) Trends in environmental analytics and monitoring. Crit Rev Anal Chem 30(2–3):221–269. https://doi.org/10.1080/10408340091164243
Berthod A, Garcia-Alvarez-Coque C (2000) Micellar liquid chromatography. CRC Press, Boca Raton
Ruiz-Angel M, Carda-Broch S, Torres-Lapasió JR, García-Álvarez-Coque M (2009) Retention mechanisms in micellar liquid chromatography. J Chromatogr A 1216(10):1798–1814. https://doi.org/10.1016/j.chroma.2008.09.053
Keith LH, Gron LU, Young JL (2007) Green analytical methodologies. Chem Rev 107:2695–2708. https://doi.org/10.1021/cr068359e
Gałuszka A, Migaszewski ZM, Konieczka P, Namieśnik J (2012) Analytical Eco-Scale for assessing the greenness of analytical procedures. TrAC Trend Anal Chem 37:61–72. https://doi.org/10.1016/j.trac.2012.03.013
Gaber Y, Törnvall U, Kumar M, Amin MA, Hatti-Kaul R (2011) HPLC-EAT (Environmental Assessment Tool): a tool for profiling safety, health and environmental impacts of liquid chromatography methods. Green Chem 13(8):2021–2025. https://doi.org/10.1039/C0GC00667J
Capello C, Hellweg S, Badertscher B, Betschart H, Hungerbühler K (2007) Environmental assessment of waste-solvent treatment options—part 1: the ecosolvent tool—environmental assessment of waste-solvent treatment options. J Ind Ecol 11:26–38. https://doi.org/10.1021/es2001248
Płotka-Wasylka J (2018) A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index. Talanta 181:204–209. https://doi.org/10.1016/j.talanta.2018.01.013
Harang V, Westerlund D (1999) Optimization of an HPLC method for the separation of erythromycin and related compounds using factorial design. Chromatographia 50(9–10):525–531
Talebianpoor M, Khodadoust S, Rozbehi A, Toori MA, Zoladl M, Ghaedi M, Mohammadi R, Hosseinzadeh A (2014) Application of optimized dispersive liquid–liquid microextraction for determination of melatonin by HPLC–UV in plasma samples. J Chromatogr B 960:1–7. https://doi.org/10.1016/j.jchromb.2014.04.013
Nemutlu E, Kır S, Katlan D, Beksac MS (2009) Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone. Talanta 80(1):117–126. https://doi.org/10.1016/j.talanta.2009.06.034
Karmarkar S, Garber R, Genchanok Y, George S, Yang X, Hammond R (2011) Quality by design (QbD) based development of a stability indicating HPLC method for drug and impurities. J Chromatogr Sci 49(6):439–446
Garg NK, Sharma G, Singh B, Nirbhavane P, Katare OP (2015) Quality by design (QbD)-based development and optimization of a simple, robust RP-HPLC method for the estimation of methotrexate. J Liq Chromatogr R T 38(17):1629–1637. https://doi.org/10.1080/10826076.2015.1087409
Habib AA, Mabrouk MM, Hammad SF, Megahed SM (1981) Implementation of factorial design for optimization of forced degradation conditions and development of validated stability indicating RP-HPLC method for Lidocaine hydrochloride. Der Pharma Chem 7:198–211
Candioti LV, De Zan MM, Camara MS, Goicoechea HC (2014) Experimental design and multiple response optimization. Using the desirability function in analytical methods development. Talanta 124:123–138. https://doi.org/10.1016/j.talanta.2014.01.034
Moffat AC, Osselton MD, Widdop B, Watts J (2011) Clarke's analysis of drugs and poisons, vol 3. Pharmaceutical press, London
Sweetman SC (2011) Martindale: the complete drug reference. Drug monographs. Pharmaceutical Press, London
Bashir S, Sherwani MUIK, Shabbir I, Batool A (2011) Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia. J Ayub Med Coll 23(3):97–100
Jani D, Shetty S, Ahmed M, Sridhar B, Shah J (2010) Simultaneous spectrophotometric estimation of atorvastatin calcium and amlodipine besylate in combined tablet dosage form by first order derivative method. Int J Chem Sci 8(1):306–314
Darwish HW, Hassan SA, Salem MY, El-Zeiny BA (2011) Three different spectrophotometric methods manipulating ratio spectra for determination of binary mixture of Amlodipine and Atorvastatin. Spectrochim Acta A 83(1):140–148. https://doi.org/10.1016/j.saa.2011.08.005
Kumbhar ST, Jadhav SD, Bhatia NM, Bhatia MS (2011) Development and validation of derivative spectrophotometric method for estimation of atorvastatin calcium and amlodipine besylate in tablet dosage form. Int J Pharm Pharm Sci 3(4):195–197
Sarrafi AH, Konoz E, Ghiyasvand M (2011) Simultaneous detemination of atorvastatin calcium and amlodipine besylate by spectrophotometry and multivariate calibration methods in pharmaceutical formulations. J Chem-NY 8(4):1670–1679
Darwish HW, Hassan SA, Salem MY, El-Zeany BA (2016) Advanced stability indicating chemometric methods for quantitation of amlodipine and atorvastatin in their quinary mixture with acidic degradation products. Spectrochim Acta A 154:58–66. https://doi.org/10.1016/j.saa.2015.10.007
Ibrahim N, Rizk M, Ibrahim A, Tawakkol S, Ali I (2014) Simultaneous determination of amlodipine besylate and atorvastatin calcium by using spectrophotometric method with multivariate calibration and hplc method implementing “design of experiment. Int J Pharm 6(1):419–425
Darwish HW, Hassan SA, Salem MY, El-Zeany BA (2013) Three different methods for determination of binary mixture of amlodipine and atorvastatin using dual wavelength spectrophotometry. Spectrochim Acta A 104:70–76. https://doi.org/10.1016/j.saa.2012.11.079
Darwish HW, Hassan SA, Salem MY, El-Zeany BA (2013) Development and validation of H-point standard addition method applied for the analysis of binary mixture of amlodipine and atorvastatin. Int J Pharm Bio Sci 4:230–243
Moussa BA, El-Zaher AA, Mahrouse MA, Ahmed MS (2013) Simultaneous determination of amlodipine besylate and atorvastatin calcium in binary mixture by spectrofluorimetry and HPLC coupled with fluorescence detection. Anal Chem Insights. https://doi.org/10.4137/ACI.S12921
Nasr JJ, Shalan S (2020) Simultaneous estimation of amlodipine and atorvastatin by micelle-augmented first derivative synchronous spectrofluorimetry and multivariate analysis. Spectrochim Acta A 224:117430. https://doi.org/10.1016/j.saa.2019.117430
Vonica-Gligor AL, Casian T, Reznek A, Gligor F (2015) Simultaneous quantification of atorvastatin and amlodipine in powder blends for tableting by NIR spectroscopy and chemometry. Farmacia 63:381–387
Chaudhari BG, Patel NM, Shah PB (2007) Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products. Chem Pharm Bull 55(2):241–246. https://doi.org/10.1248/cpb.55.241
Shah D, Bhatt K, Mehta R, Baldania S, Gandhi T (2008) Stability indicating RP-HPLC estimation of atorvastatin calcium and amlodipine besylate in pharmaceutical formulations. Indian J Pharm Sci 70(6):754. https://doi.org/10.4103/0250-474X.49117
Sharma AK, Dharamsi A (2012) Development and validation of RP-HPLC and spectrophotometric method for simultaneous estimation of atorvastatin and amlodipine in pharmaceutical dosage forms. Int J Pharm 3:1202–1207
Acharjya SK, Annapurna MM, Koya S (2010) Liquid chromatographic method for simultaneous estimation of atorvastatin calcium and amlodipine besylate in pharmaceutical dosage forms. IJPBS 1:161–170
Yacoub M, Alawi M, Arafat T (2013) Simultaneous determination of amlodipine and atorvastatin with its metabolites; ortho and para hydroxy atorvastatin; in human plasma by LC–MS/MS. J Chromatogr B917:36–47. https://doi.org/10.1016/j.jchromb.2013.01.001
Liu W, Zhang Q (2010) Determination of amlodipine besylate and atorvastatin calcium in human plasma by LC-MS/MS. Herald Med 6:301–312
Haritha P, Rao BS, Sunandamma Y (2014) Method development and validation for simultaneous determination of Amlodipine besylate and atorvastatin calcium by RP-HPLC technique. Asian J Res Chem 4:438–445
Zhou Y, Li J, He X, Jia M, Liu M, Li H, Xiong Z, Fan Y, Li W (2013) Development and validation of a liquid chromatography–tandem mass spectrometry method for simultaneous determination of amlodipine, atorvastatin and its metabolites ortho-hydroxy atorvastatin and para-hydroxy atorvastatin in human plasma and its application in a bioequivalence study. J Pharm Biomed Anal 83:101–107. https://doi.org/10.1016/j.jpba.2013.04.021
Patel VB, Sahu R, Patel BM (2011) Simultaneous determination of amlodipine besylate and atorvastatin calcium in pharmaceutical tablet formulation by high performance thin layer chromatographic method. Int J Chem Tech Res 3(2):695–698. https://doi.org/10.1002/jssc.200700148
Hassan SA, Elzanfaly ES, El-Zeany SBA, Salem MY (2016) Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets. Acta Pharma 66(4):479–490. https://doi.org/10.1515/acph-2016-0040
Hefnawy MM, Sultan M, Al-Johar H (2009) Development of capillary electrophoresis technique for simultaneous measurement of amlodipine and atorvastatin from their combination drug formulations. J Liq Chromatogr Relat Technol 32(20):2923–2942. https://doi.org/10.1080/10826070903320681
Dogan-Topal B, Bozal B, Demircigil BT, Uslu B, Ozkan SA (2009) Electroanalytical studies and simultaneous determination of amlodipine besylate and atorvastatine calcium in binary mixtures using first derivative of the ratio-voltammetric methods. Electroanalysis 21(22):2427–2439. https://doi.org/10.1002/elan.200904689
Mohammadi A, Moghaddam AB, Eilkhanizadeh K, Alikhani E, Mozaffari S, Yavari T (2013) Electro-oxidation and simultaneous determination of amlodipine and atorvastatin in commercial tablets using carbon nanotube modified electrode. Micro Nano Lett 8:413–417. https://doi.org/10.1049/mnl.2013.0080
Sivakumar T, Manavalan R, Muralidharan C, Valliappan K (2007) An improved HPLC method with the aid of a chemometric protocol: simultaneous analysis of amlodipine and atorvastatin in pharmaceutical formulations. J Sep Sci 30(18):3143–3153
Koller G, Fischer U, Hungerbühler K (2000) Assessing safety, health, and environmental impact early during process development. Ind Eng Chem 39(4):960–972. https://doi.org/10.1021/ie990669i
International Conference on Harmonization (ICH) (2005) ICH Harmonised tripartite guideline: Validation of analytical procedures: text and methodology Q2 (R1)
The United States Pharmacopeia, USP 40, Online version, 2017, US Pharmacopeial Convention, Rockville. (https://www.uspnf.com), Accessed 25 Mar 2020
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Habib, A.A., Hammad, S.F., Megahed, S.M. et al. Innovative Quality by Design Approach for Development of Green Micellar HPLC Method for Simultaneous Determination of Atorvastatin and Amlodipine. Chromatographia 83, 1221–1231 (2020). https://doi.org/10.1007/s10337-020-03937-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-020-03937-5